Selecting participants when testing new drugs: the implications of age and gender discrimination

    Research output: Contribution to journalArticle

    7 Citations (Scopus)

    Abstract

    Pharmaceutical products are rigorously tested for safety and efficacy prior to being licensed for use. During this testing process the archetypal research subject is a young male; women and older people are less frequently invited to participate. This is especially true at the early stages, but can also occur in the later phases of drug testing. This paper considers the reasons for the relative under-representation of these groups, and the legal implications of failing to include as research subjects the very types of people who will ultimately consume these drugs.
    Original languageEnglish
    Pages (from-to)130-134
    Number of pages5
    JournalMedico-Legal Journal
    Volume70
    Issue number3
    DOIs
    Publication statusPublished - Sep 2002

    Fingerprint

    Ageism
    Research Subjects
    Pharmaceutical Preparations
    Safety

    Keywords

    • Drug testing
    • Women
    • Older patients
    • Legal liability
    • Medical research
    • Clinical trials
    • Health
    • Discrimination

    Cite this

    @article{5f10c173e5984328a2af54ccbf99969b,
    title = "Selecting participants when testing new drugs: the implications of age and gender discrimination",
    abstract = "Pharmaceutical products are rigorously tested for safety and efficacy prior to being licensed for use. During this testing process the archetypal research subject is a young male; women and older people are less frequently invited to participate. This is especially true at the early stages, but can also occur in the later phases of drug testing. This paper considers the reasons for the relative under-representation of these groups, and the legal implications of failing to include as research subjects the very types of people who will ultimately consume these drugs.",
    keywords = "Drug testing, Women, Older patients, Legal liability, Medical research, Clinical trials, Health, Discrimination",
    author = "Ferguson, {Pamela R.}",
    note = "dc.publisher: RSM Press dc.description.sponsorship: Royal Society of Edinburgh",
    year = "2002",
    month = "9",
    doi = "10.1258/rsmmlj.70.3.130",
    language = "English",
    volume = "70",
    pages = "130--134",
    journal = "Medico-Legal Journal",
    issn = "0025-8172",
    publisher = "SAGE Publications",
    number = "3",

    }

    Selecting participants when testing new drugs: the implications of age and gender discrimination. / Ferguson, Pamela R.

    In: Medico-Legal Journal, Vol. 70, No. 3, 09.2002, p. 130-134.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Selecting participants when testing new drugs: the implications of age and gender discrimination

    AU - Ferguson, Pamela R.

    N1 - dc.publisher: RSM Press dc.description.sponsorship: Royal Society of Edinburgh

    PY - 2002/9

    Y1 - 2002/9

    N2 - Pharmaceutical products are rigorously tested for safety and efficacy prior to being licensed for use. During this testing process the archetypal research subject is a young male; women and older people are less frequently invited to participate. This is especially true at the early stages, but can also occur in the later phases of drug testing. This paper considers the reasons for the relative under-representation of these groups, and the legal implications of failing to include as research subjects the very types of people who will ultimately consume these drugs.

    AB - Pharmaceutical products are rigorously tested for safety and efficacy prior to being licensed for use. During this testing process the archetypal research subject is a young male; women and older people are less frequently invited to participate. This is especially true at the early stages, but can also occur in the later phases of drug testing. This paper considers the reasons for the relative under-representation of these groups, and the legal implications of failing to include as research subjects the very types of people who will ultimately consume these drugs.

    KW - Drug testing

    KW - Women

    KW - Older patients

    KW - Legal liability

    KW - Medical research

    KW - Clinical trials

    KW - Health

    KW - Discrimination

    U2 - 10.1258/rsmmlj.70.3.130

    DO - 10.1258/rsmmlj.70.3.130

    M3 - Article

    VL - 70

    SP - 130

    EP - 134

    JO - Medico-Legal Journal

    JF - Medico-Legal Journal

    SN - 0025-8172

    IS - 3

    ER -